1
|
Malbos M, Wakeling E, Gautier T, Boespflug-Tanguy O, Busby L, Taylor-Miller T, Dudoignon B, Bokov P, Govin J, Grisval M, Rega A, Mourot De Rougemont MG, Aubriot-Lorton MH, Darmency V, Bensignor C, Houzel A, Huet F, Denommé-Pichon AS, Delanne J, Tran Mau-Them F, Bruel AL, Safraou H, Nambot S, Garde A, Philippe C, Duffourd Y, Vitobello A, Faivre L, Thauvin-Robinet C. Further description of two individuals with de novo p.(Glu127Lys) missense variant in the ASCL1 gene. Clin Genet 2024; 105:555-560. [PMID: 38287449 DOI: 10.1111/cge.14485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2023] [Revised: 12/21/2023] [Accepted: 01/05/2024] [Indexed: 01/31/2024]
Abstract
Achaete-Scute Family basic-helix-loop-helix (bHLH) Transcription Factor 1 (ASCL1) is a proneural transcription factor involved in neuron development in the central and peripheral nervous system. While initially suspected to contribute to congenital central hypoventilation syndrome-1 (CCHS) with or without Hirschsprung disease (HSCR) in three individuals, its implication was ruled out by the presence, in one of the individuals, of a Paired-like homeobox 2B (PHOX2B) heterozygous polyalanine expansion variant, known to cause CCHS. We report two additional unrelated individuals sharing the same sporadic ASCL1 p.(Glu127Lys) missense variant in the bHLH domain and a common phenotype with short-segment HSCR, signs of dysautonomia, and developmental delay. One has also mild CCHS without polyalanine expansion in PHOX2B, compatible with the diagnosis of Haddad syndrome. Furthermore, missense variants with homologous position in the same bHLH domain in other genes are known to cause human diseases. The description of additional individuals carrying the same variant and similar phenotype, as well as targeted functional studies, would be interesting to further evaluate the role of ASCL1 in neurocristopathies.
Collapse
Affiliation(s)
- Marlène Malbos
- CRMRs "Anomalies du Développement et syndromes malformatifs" et "Déficiences Intellectuelles de causes rares", Centre de Génétique, CHU Dijon, Dijon, France
| | - Emma Wakeling
- North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
| | - Thierry Gautier
- Université Grenoble Alpes, Inserm-U1209, CNRS-UMR5309, Institut pour l'Avancée des Biosciences, Grenoble, France
| | - Odile Boespflug-Tanguy
- Université Paris-Cité, INSERM-UMR1141, CRMR « Leucodystrophies », Neurologie Pédiatrique et Maladies métaboliques, Hôpital Robert-Debré, AP-HP, Paris, France
| | - Louise Busby
- Rare & Inherited Disease Laboratory, London North Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
| | - Tashunka Taylor-Miller
- Rare & Inherited Disease Laboratory, London North Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK
| | - Benjamin Dudoignon
- Université Paris-Cité, AP-HP, Hôpital Robert-Debré, Physiologie Pédiatrique-Centre du Sommeil-CRMR Hypoventilations alvéolaires rares, INSERM, Paris, France
| | - Plamen Bokov
- Université Paris-Cité, AP-HP, Hôpital Robert-Debré, Physiologie Pédiatrique-Centre du Sommeil-CRMR Hypoventilations alvéolaires rares, INSERM, Paris, France
| | - Jérôme Govin
- Université Grenoble Alpes, Inserm-U1209, CNRS-UMR5309, Institut pour l'Avancée des Biosciences, Grenoble, France
| | - Margot Grisval
- CRMRs "Anomalies du Développement et syndromes malformatifs" et "Déficiences Intellectuelles de causes rares", Centre de Génétique, CHU Dijon, Dijon, France
| | | | | | | | | | - Candace Bensignor
- CCMR "Maladies Endocriniennes de la Croissance et du Développement", CHU Dijon, Dijon, France
| | - Anne Houzel
- Pneumologie Pédiatrique, CHU Dijon, Dijon, France
| | - Frédéric Huet
- Pédiatrie pluridisciplinaire, CHU Dijon, Dijon, France
| | - Anne-Sophie Denommé-Pichon
- UF "Innovation diagnostique dans les maladies rares", CHU Dijon, Dijon, France
- Inserm-UB-UMR1231 GAD, Dijon, France
| | - Julian Delanne
- CRMRs "Anomalies du Développement et syndromes malformatifs" et "Déficiences Intellectuelles de causes rares", Centre de Génétique, CHU Dijon, Dijon, France
| | - Frédéric Tran Mau-Them
- UF "Innovation diagnostique dans les maladies rares", CHU Dijon, Dijon, France
- Inserm-UB-UMR1231 GAD, Dijon, France
| | - Ange-Line Bruel
- UF "Innovation diagnostique dans les maladies rares", CHU Dijon, Dijon, France
- Inserm-UB-UMR1231 GAD, Dijon, France
| | - Hana Safraou
- UF "Innovation diagnostique dans les maladies rares", CHU Dijon, Dijon, France
- Inserm-UB-UMR1231 GAD, Dijon, France
| | - Sophie Nambot
- CRMRs "Anomalies du Développement et syndromes malformatifs" et "Déficiences Intellectuelles de causes rares", Centre de Génétique, CHU Dijon, Dijon, France
- UF "Innovation diagnostique dans les maladies rares", CHU Dijon, Dijon, France
| | - Aurore Garde
- CRMRs "Anomalies du Développement et syndromes malformatifs" et "Déficiences Intellectuelles de causes rares", Centre de Génétique, CHU Dijon, Dijon, France
| | - Christophe Philippe
- UF "Innovation diagnostique dans les maladies rares", CHU Dijon, Dijon, France
- Inserm-UB-UMR1231 GAD, Dijon, France
| | | | - Antonio Vitobello
- UF "Innovation diagnostique dans les maladies rares", CHU Dijon, Dijon, France
- Inserm-UB-UMR1231 GAD, Dijon, France
| | - Laurence Faivre
- CRMRs "Anomalies du Développement et syndromes malformatifs" et "Déficiences Intellectuelles de causes rares", Centre de Génétique, CHU Dijon, Dijon, France
- UF "Innovation diagnostique dans les maladies rares", CHU Dijon, Dijon, France
| | - Christel Thauvin-Robinet
- CRMRs "Anomalies du Développement et syndromes malformatifs" et "Déficiences Intellectuelles de causes rares", Centre de Génétique, CHU Dijon, Dijon, France
- UF "Innovation diagnostique dans les maladies rares", CHU Dijon, Dijon, France
| |
Collapse
|
2
|
Arthurs OJ, Rega A, Guimiot F, Belarbi N, Rosenblatt J, Biran V, Elmaleh M, Sebag G, Alison M. Diffusion-weighted magnetic resonance imaging of the fetal brain in intrauterine growth restriction. Ultrasound Obstet Gynecol 2017; 50:79-87. [PMID: 27706859 DOI: 10.1002/uog.17318] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/11/2016] [Revised: 08/23/2016] [Accepted: 09/22/2016] [Indexed: 06/06/2023]
Abstract
OBJECTIVE Diffusion-weighted magnetic resonance imaging (DWI) is a sensitive method for assessing brain maturation and detecting brain lesions, providing apparent diffusion coefficient (ADC) values as a measure of water diffusion. Abnormal ADC values are seen in ischemic brain lesions, such as those associated with acute or chronic hypoxia. The aim of this study was to assess whether ADC values in the fetal brain were different in fetuses with severe intrauterine growth restriction (IUGR) compared with normal controls. METHODS Brain magnetic resonance imaging (MRI) with single-shot axial DWI (b = 0 and b = 700 s/mm2 ) was performed in 30 fetuses with severe IUGR (estimated fetal weight < 3rd centile with absent or reversed umbilical artery Doppler flow) and in 24 normal controls of similar gestational age. Brain morphology and biometry were analyzed. ADC values were measured in frontal and occipital white matter, centrum semiovale, thalami, cerebellar hemisphere and pons. Frontal-occipital and frontal-cerebellar ADC ratios were calculated, and values were compared between IUGR fetuses and controls. RESULTS There was no difference in gestational age at MRI between IUGR and control fetuses (IUGR, 30.2 ± 1.6 weeks vs controls, 30.7 ± 1.4 weeks). Fetal brain morphology and signals were normal in all fetuses. Brain dimensions (supratentorial ± infratentorial) were decreased (Z-score, < -2) in 20 (66.7%) IUGR fetuses. Compared with controls, IUGR fetuses had significantly lower ADC values in frontal white matter (1.97 ± 0.23 vs 2.17 ± 0.22 × 10-3 mm2 /s; P < 0.0001), thalami (1.04 ± 0.15 vs 1.13 ± 0.10 ×10-3 mm2 /s; P = 0.0002), centrum semiovale (1.86 ± 0.22 vs 1.97 ± 0.23 ×10-3 mm2 /s; P = 0.01) and pons (0.85 ± 0.19 vs 0.94 ± 0.12 ×10-3 mm2 /s; P = 0.043). IUGR fetuses had a lower frontal-occipital ADC ratio than did normal fetuses (1.00 ± 0.11 vs 1.08 ± 0.05; P = 0.003). CONCLUSIONS ADC values in IUGR fetuses were significantly lower than in normal controls in the frontal white matter, thalami, centrum semiovale and pons, suggesting abnormal maturation in these regions. However, the prognostic value of these ADC changes is still unknown. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.
Collapse
Affiliation(s)
- O J Arthurs
- Department of Pediatric Radiology, Robert Debré Hospital, AP-HP, Paris, France
| | - A Rega
- Department of Pediatric Radiology, Robert Debré Hospital, AP-HP, Paris, France
| | - F Guimiot
- Department of Developmental Biology, Robert Debré Hospital, AP-HP, University Paris Diderot, Paris, France
- University Paris Diderot, Paris 7, PRES Sorbonne Paris-Cité, INSERM U1141, DHU PROTECT, Paris, France
| | - N Belarbi
- Department of Pediatric Radiology, Robert Debré Hospital, AP-HP, Paris, France
| | - J Rosenblatt
- Department of Gynecology and Obstetrics, Robert Debré Hospital, AP-HP, Paris, France
| | - V Biran
- University Paris Diderot, Paris 7, PRES Sorbonne Paris-Cité, INSERM U1141, DHU PROTECT, Paris, France
- Neonatal Intensive Care Unit, Robert Debré Hospital, AP-HP, University Paris Diderot, Paris, France
| | - M Elmaleh
- Department of Pediatric Radiology, Robert Debré Hospital, AP-HP, Paris, France
| | - G Sebag
- Department of Pediatric Radiology, Robert Debré Hospital, AP-HP, Paris, France
- University Paris Diderot, Paris 7, PRES Sorbonne Paris-Cité, INSERM U1141, DHU PROTECT, Paris, France
| | - M Alison
- Department of Pediatric Radiology, Robert Debré Hospital, AP-HP, Paris, France
- University Paris Diderot, Paris 7, PRES Sorbonne Paris-Cité, INSERM U1141, DHU PROTECT, Paris, France
| |
Collapse
|
3
|
Cardoen L, Schiff M, Lambron J, Rega A, Virlouvet AL, Biran V, Eleni Dit Trolli S, Elmaleh-Bergès M, Alison M. [Neonatal presentation of maple syrup urine disease]. Arch Pediatr 2016; 23:1291-1294. [PMID: 27816400 DOI: 10.1016/j.arcped.2016.09.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2016] [Accepted: 09/03/2016] [Indexed: 10/20/2022]
Affiliation(s)
- L Cardoen
- Service de radiologie pédiatrique, hôpital Robert-Debré, université Paris Diderot, PRES Sorbonne Paris-Cité, AP-HP, 75019 Paris, France
| | - M Schiff
- Service de neurologie pédiatrique, centre de référence des maladies métaboliques congénitales, université Paris Diderot, PRES Sorbonne Paris-Cité, 75019 Paris, France; Inserm U1141, DHU PROTECT, 75019 Paris, France
| | - J Lambron
- Service de radiologie pédiatrique, hôpital Robert-Debré, université Paris Diderot, PRES Sorbonne Paris-Cité, AP-HP, 75019 Paris, France
| | - A Rega
- Service de radiologie pédiatrique, hôpital Robert-Debré, université Paris Diderot, PRES Sorbonne Paris-Cité, AP-HP, 75019 Paris, France
| | - A-L Virlouvet
- Service de néonatologie, hôpital Robert-Debré, université Paris Diderot, PRES Sorbonne Paris-Cité, AP-HP, 75019 Paris, France
| | - V Biran
- Inserm U1141, DHU PROTECT, 75019 Paris, France; Service de néonatologie, hôpital Robert-Debré, université Paris Diderot, PRES Sorbonne Paris-Cité, AP-HP, 75019 Paris, France
| | - S Eleni Dit Trolli
- Service de réanimation pédiatrique et médecine néonatale, hôpital Bicêtre, AP-HP, 94270 Le Kremlin-Bicêtre, France
| | - M Elmaleh-Bergès
- Service de radiologie pédiatrique, hôpital Robert-Debré, université Paris Diderot, PRES Sorbonne Paris-Cité, AP-HP, 75019 Paris, France
| | - M Alison
- Service de radiologie pédiatrique, hôpital Robert-Debré, université Paris Diderot, PRES Sorbonne Paris-Cité, AP-HP, 75019 Paris, France; Inserm U1141, DHU PROTECT, 75019 Paris, France.
| |
Collapse
|
4
|
Cardoen L, Schiff M, Lambron J, Rega A, Virlouvet AL, Biran V, Eleni Dit Trolli S, Elmaleh-Bergès M, Alison M. [Neonatal weight loss with neurological degeneration]. Arch Pediatr 2016; 23:1273-1275. [PMID: 27816399 DOI: 10.1016/j.arcped.2016.09.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2016] [Accepted: 09/03/2016] [Indexed: 11/24/2022]
Affiliation(s)
- L Cardoen
- Service de radiologie pédiatrique, hôpital Robert-Debré, université Paris Diderot, PRES Sorbonne Paris-Cité, AP-HP, 75019 Paris, France
| | - M Schiff
- Service de neurologie pédiatrique, centre de référence des maladies métaboliques congénitales, université Paris Diderot, PRES Sorbonne Paris-Cité, 75019 Paris, France; Inserm U1141, DHU PROTECT, 75019 Paris, France
| | - J Lambron
- Service de radiologie pédiatrique, hôpital Robert-Debré, université Paris Diderot, PRES Sorbonne Paris-Cité, AP-HP, 75019 Paris, France
| | - A Rega
- Service de radiologie pédiatrique, hôpital Robert-Debré, université Paris Diderot, PRES Sorbonne Paris-Cité, AP-HP, 75019 Paris, France
| | - A-L Virlouvet
- Service de néonatologie, hôpital Robert-Debré, université Paris Diderot, PRES Sorbonne Paris-Cité, AP-HP, 75019 Paris, France
| | - V Biran
- Inserm U1141, DHU PROTECT, 75019 Paris, France; Service de néonatologie, hôpital Robert-Debré, université Paris Diderot, PRES Sorbonne Paris-Cité, AP-HP, 75019 Paris, France
| | - S Eleni Dit Trolli
- Service de réanimation pédiatrique et médecine néonatale, hôpital Bicêtre, AP-HP, 94270 Le Kremlin-Bicêtre, France
| | - M Elmaleh-Bergès
- Service de radiologie pédiatrique, hôpital Robert-Debré, université Paris Diderot, PRES Sorbonne Paris-Cité, AP-HP, 75019 Paris, France
| | - M Alison
- Service de radiologie pédiatrique, hôpital Robert-Debré, université Paris Diderot, PRES Sorbonne Paris-Cité, AP-HP, 75019 Paris, France; Inserm U1141, DHU PROTECT, 75019 Paris, France.
| |
Collapse
|
5
|
Muller C, Berrebi D, Malbezin S, Rega A, El Ghoneimi A, Bonnard A. SFCP CO-09 - Variation de marquage par la calrétinine dans les formes courtes de Maladie de Hirschsprung : un facteur pronostic ? Arch Pediatr 2014. [DOI: 10.1016/s0929-693x(14)71647-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
6
|
Alison M, Tanase A, Rega A, Gabor F, Tilea B, Sebag G. Imagerie des infections ostéo-articulaires de l’enfant. Arch Pediatr 2014. [DOI: 10.1016/s0929-693x(14)71518-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
7
|
Rega A, Tanase A, Pommelet V, Chauty A, Ardant M, Alison M, Sebag G. SFIPP P-08 - Aspect radiologiques des atteintes osseuses à Mycobacterium Ulcerans. Arch Pediatr 2014. [DOI: 10.1016/s0929-693x(14)71857-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
8
|
Thikkurissy S, Pavone A, Rega A, Bae R, Roy M, Wishe HI, Kiremidjian-Schumacher L. Effect of interleukin-2 and selenium on the growth of squamous cell carcinoma cells. Otolaryngol Head Neck Surg 2001; 124:142-9. [PMID: 11226946 DOI: 10.1067/mhn.2001.112878] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVES The objectives of this study were to determine whether the expression of the interleukin-2 (IL-2) receptors on squamous cell carcinoma cells can be enhanced in the presence of selenium (Se) and contribute to a greater retardation of tumor growth after locoregional therapy with IL-2. STUDY DESIGN The growth of the cells was studied after in vitro or dietary supplementation with Se in a murine model. RESULTS Treatment of established tumors in hosts supplemented with Se with peritumoral injections of IL-2 resulted in 50% reduction of tumor size, whereas treatment of early tumors resulted in 72.4% reduction. The effect was most likely related to a combination of enhanced immune responsiveness and enhanced IL-2 receptor expression on the tumor cells. CONCLUSIONS AND SIGNIFICANCE The data suggested that local immunotherapy with IL-2 in hosts supplemented with Se may represent an effective modality of treatment for the prevention of recurrences at the site of conventionally treated primary tumors, including tumors that do not express IL-2 receptors.
Collapse
Affiliation(s)
- S Thikkurissy
- New York University College of Dentistry, New York, NY 10010, USA
| | | | | | | | | | | | | |
Collapse
|
9
|
Cindolo L, Rega A, Marsicano M, Ginestra A, Guadagno V, Altieri V. ["Classic" vs autolubricant catheterization for endovesicular chemotherapy. Preliminary experience]. MINERVA UROL NEFROL 1999; 51:181-5. [PMID: 10638184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
Abstract
AIM The aim of this study was to evaluate the frequency of urinary tract infections (UTI) after catheterisation for instillation comparing two systems: the "classic" method and the catheterisation using a new autolubricant device: EasiCath Coloplast. METHODS During the period of endovesical chemotherapy (between 4 and 48 weeks), 22 patients (6 females and 18 males) were studied, aged between 53 and 78 years old. We have performed 139 instillations using Nelaton Ch 14 or 12 type catheters lubricated with gel based on lidocaine, neomicyn and fluocinolone ("classic" method). Instead 135 patients have been treated with autolubricant devices according to the manufacturer's instructions. After 48 hours from instillation, a total of 274 catheterisation have been examined using urine tests and urine culture with antibiogram. We administered a 5-point visual analogic score to the patients weighing the post-instillation dysuria. RESULTS With "classic" method UTI frequency is 7.19% (10/139). The most common pathogen has been E. coli (7/10). With autolubricant catheters UTI frequency is 2.96 (4/135). Klebsiella, Enterobacter, as well as E. coli (2/4) have been identified as pathogen. All patients with infections have been treated with targeted antibiotics based on the antibiogram. CONCLUSIONS We have observed the people with autolubricant catheters left more comfort then those undergoing to the "classic" catheterisation. The frequency of post-catheterisation, dysuria was also reduced. Our data show that the new method is safer and easier to handle then the "classic" one. Moreover, common anaesthetic/antibiotic lubricant have important bacteriostatic effects that reduce the BCG viability.
Collapse
Affiliation(s)
- L Cindolo
- Clinica Urologica, Azienda Universitaria Policlinico, Napoli
| | | | | | | | | | | |
Collapse
|
10
|
Altieri V, Setola P, Ottaviano N, Ucciero G, Scognamiglio G, Montanaro V, Giannella R, Rega A, Lotti T. [Imaging diagnosis of non-lymph node metastasis of bladder carcinoma]. Arch Ital Urol Androl 1994; 66:223-8. [PMID: 7812300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
Assessment of presence of metastatic disease (m.d.) in bladder cancer (b.c.) can represent a main problem as influencing the appropriate therapeutic policy (mostly the indication to radical surgery). Evaluation of the real cost-effectiveness ratio of radiographic and radionuclide diagnostic work-up induced us to retrospectively review historical data about our b.c. patients (pts). From March 1988 to June 1991, 76 not consecutive pts with histologically proven bladder cancer were included in this study. 5 Pts were staged as T1, 25 as T2, 18 as T3a, 23 as T3b, 5 as T4. 2 Pts were graded as G1, 27 as G2, 44 as G3, 3 as Gx. Age varied from 39 to 89 years (average: 62.3). 79 Pts underwent the "basic work-up" (including chest plain film, bone and liver scans) and at least one follow-up control. 266 chest plain films, 22 chest x-ray tomograms, 2 chest CT scans, 27 bone x-ray tomograms, 231 bone scans, 240 liver scans, 17 liver ultrasonographies were totally realized. All pts underwent at least an abdomen-pelvic CT, but related results are not considered in the study. Fine needle aspiration cytologic biopsies were realized in selected cases; also these results are not selectively reported here. Together with cytologic positive results, only progression of m.d. was considered as its definite presence. Conventional x-ray examination (plain film integrated by x-ray tomograms of "suspicious" findings) resulted sufficiently complete and accurate to reveal chest m.d. Concerning skeletal diagnostic survey, only 6 pts (26%) out of 23 pts with "positive" bone scans really resulted affected by m.d.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- V Altieri
- Clinica Urologica-II Facoltà di Medicina e Chirurgia dell'Università degli Studi di Napoli, Federico II
| | | | | | | | | | | | | | | | | |
Collapse
|